Cardiovascular Markers With retatrutides visceral fat drop often comes improved heart health metrics
7 Wegovy 7.2 mg (MHRA-approved January 2026): 18.7% on average over 72 weeks, rising to 20.7% in fully adherent participants, closer to Mounjaros results, though still below retatrutide
Even though human studies have not shown the same effect, these drugs should not be used by people with a personal or family history of multiple endocrine neoplasia syndrome type 2 (MEN 2), a rare cancer that increases the risk for thyroid tumors
Always consult your prescriber before making changes to any medication.
Always consult a qualified healthcare provider before making significant changes to your diet, exercise routine, or overall health plan
How Should I Rotate Sites